SUVEN PHARMACEUTICALS
Sector : Pharmaceuticals | Midcap | BSE
Suven Pharmaceuticals, operating in the Pharmaceuticals sector and classified as a Midcap on the bse, currently has its share price at 1079.35 The stock has experienced fluctuations today, with a low of ₹1066.95 and a high of ₹1094 Over the past 52 weeks, the shares have seen a low of ₹586.1 and a high of ₹1359.
In terms of performance, Suven Pharmaceuticals has shown a return of 0.74% in one day, -14.83% over the past month, and -13.79% in the last three months.
Analyzing the technicals, the daily pivot level for the stock is set at 1078.83. The resistance levels are identified as R1 at 1090.72, R2 at 1105.88, and R3 at 1117.77. On the support side, the levels are marked as S1 at 1063.67, S2 at 1051.78, and S3 at 1036.62.
In the realm of technical analysis for our subject stock, the moving averages present a detailed picture. Over a short span of 5 days, the Simple Moving Average (SMA) stands at 1074.45, while the Exponential Moving Average (EMA) is noted at 1064.69. Extending the view to a 10-day period, the SMA adjusts to 1090.13 with the EMA slightly differing at 1084.29.
In a comparative analysis of stock performance within its sector, Suven Pharmaceuticals stands alongside several key competitors, each showcasing varied performance metrics over different time periods. Suven Pharmaceuticals itself has recorded performance figures of 1W % is 1.62 over the past week, -14.74% in the last month, and -13.7% over the past three months. Its six-month, one-year, three-year, and five-year performances are 6 month % is 23.2, 1yr % is 61.69, 3Y % is 100.47, and 5Y % is 542.35 respectively.
Read More
0.869.25
As on Jan 17, 2025, 11:13 AM | IST
Suven Pharmaceuticals Share Price Performance
Today's LowToday's High
₹1,066.95₹1,094.00
₹1,079.35
52 Weeks' Low52 Weeks' High
₹586.10₹1,359.00
₹1,079.35
Open Price
₹1,094.00
Prev. Close
₹1,070.10
Volume
3,690
Suven Pharmaceuticals Stock in Focus
- 09 Dec 2024Suven Pharmaceuticals has signed definitive agreements to acquire a 56% equity stake in NJ Bio, Inc. The $64.4 million deal includes both primary equity infusion and secondary acquisition. As part of the deal, Suven Pharma will invest $15 million in primary equity to accelerate NJ Bio’s growth initiatives. The transaction includes acquiring 9.3 lakh common equity shares from existing shareholders of NJ Bio and subscribing to 2.8 lakh newly issued common equity shares.
- 09 Sep 2024The US Food & Drug Administration (US FDA) has classified Suven Pharma subsidiary Casper Pharma’s formulations manufacturing facility in Hyderabad as ‘Voluntary Action Indicated’ (VAI). Following this classification, the US FDA has officially closed its inspection of the facility.
- 14 Jun 2024The company has executed definitive agreements to acquire 100% of the shares in Sapala Organics for Rs 2.3 billion. As part of the deal, the company will initially acquire 67.5% of the shares through a secondary transfer from Sapala Organics’ existing shareholders.
- 03 Jan 2024Suven Pharma’s board approved the appointment of Himanshu Agarwal as Chief Financial Officer, effective from January 2, 2024. Subba Rao Purapalli is set to step down from the CFO position on the same date.
Financials
Suven Pharmaceuticals Stock Technicals
Pivot Level
| R1 | 1,090.72 | |
| R2 | 1,105.88 | |
| R3 | 1,117.77 | |
Pivot 1,078.83 | ||
| S1 | 1,063.67 | |
| S2 | 1,051.78 | |
| S3 | 1,036.62 | |
Moving Average
| Day | SMA | EMA |
|---|---|---|
| 5 | 1,074.45 | 1,064.69 |
| 10 | 1,090.13 | 1,084.29 |
| 20 | 1,132.75 | 1,122.72 |
| 50 | 1,225.79 | 1,174.76 |
| 100 | 1,204.85 | 1,145.66 |
| 200 | 977.76 | 1,026.69 |
Suven Pharmaceuticals Share Peer Comparision
Name | 1W% | 1M% | 3M% | 6M% | 1Y% | 3Y% | 5Y% |
|---|---|---|---|---|---|---|---|
| 1.62 | -14.74 | -13.70 | 23.20 | 61.69 | 100.47 | 542.35 | |
| 0.22 | 0.03 | -5.29 | 12.32 | 37.77 | 109.80 | 293.88 | |
| 2.25 | 0.80 | -2.98 | 28.67 | 58.14 | 27.36 | 209.75 | |
| -1.60 | -0.28 | -7.18 | -3.95 | 11.83 | 58.87 | 201.20 | |
| -4.14 | 4.02 | -3.12 | -2.62 | 14.97 | 38.88 | 113.96 | |
| -3.03 | -6.01 | -6.46 | 4.02 | 28.70 | 99.34 | 216.63 | |
| -6.28 | -3.56 | -4.32 | 19.98 | 16.61 | 80.21 | 80.21 | |
| -0.88 | 2.65 | -2.52 | -16.04 | 40.29 | 127.19 | 269.83 | |
| -4.33 | 2.43 | -3.74 | 15.37 | 49.68 | 122.34 | 173.49 | |
| -3.75 | -4.80 | -21.32 | -13.63 | 6.17 | 68.46 | 137.56 | |
| -2.40 | -2.69 | -12.92 | -0.42 | 3.76 | 46.60 | 124.37 | |
| -4.53 | -1.86 | -3.27 | -4.49 | 6.82 | 56.80 | 118.56 | |
| 8.42 | 11.44 | 15.31 | 13.99 | 39.74 | 9.49 | 34.62 | |
| -5.41 | -3.65 | -16.00 | 3.29 | 67.17 | 182.05 | 304.65 | |
| -5.45 | -0.99 | -6.48 | 25.77 | 37.47 | 45.00 | 150.04 | |
| 0.11 | -1.18 | -12.50 | 24.27 | 25.89 | 84.60 | 275.60 | |
| -6.71 | -9.78 | -22.94 | -20.33 | -10.11 | 17.55 | 25.57 | |
| 4.29 | -11.28 | 2.99 | 54.87 | 67.62 | 23.43 | 23.43 | |
| -3.82 | -1.78 | 20.31 | 22.84 | 36.33 | 10.55 | 594.21 | |
| -5.23 | -3.43 | 3.13 | -15.80 | -13.44 | -54.22 | -7.11 |
Suven Pharmaceuticals Share Holdings
Suven Pharmaceuticals Stock Mutual Fund Holdings
Fund Name | No. Of Shares | % of AUM | Amount Invested (in ₹ crore) |
|---|---|---|---|
| DSP Healthcare Fund | 24,89,539 | 8.49 | 283.5 |
| DSP ELSS Tax Saver Fund | 23,91,260 | 1.64 | 272.3 |
| HSBC Small Cap Fund - Regular Plan | 22,98,085 | 1.51 | 261.69 |
| UTI Flexi Cap Fund | 20,56,270 | 0.9 | 234.16 |
| DSP Flexi Cap Fund | 19,91,510 | 1.96 | 226.78 |
| DSP Equity Opportunities Fund | 18,08,027 | 1.47 | 205.89 |
| Tata Small Cap Fund | 13,96,004 | 1.64 | 158.97 |
| Invesco India Contra Fund | 13,89,871 | 0.87 | 158.27 |
| 360 ONE Focused Equity Fund | 13,07,869 | 2.09 | 148.93 |
| DSP Equity & Bond Fund | 13,02,108 | 1.44 | 148.28 |
Suven Pharmaceuticals Corporate Actions
Suven Pharmaceutical - Announcement under Regulation 30 (LODR)-Investor Presentation Investor Presentation 15-Jan, 2025 | 09:54 AM |
Suven Pharmaceutical - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 Compliance Certificate under regulation 74 (5) of SEBI (DP) Regulations 2018 10-Jan, 2025 | 08:14 PM |
Suven Pharmaceutical - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation Investors Meet 08-Jan, 2025 | 07:22 PM |
Suven Pharmaceutical - Update On Merger Update on merger 01-Jan, 2025 | 05:21 PM |
Suven Pharmaceutical - Board Meeting Intimation for Approval Of Unaudited Financial Results Suven Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/02/2025 ,inter alia, to consider and approve Unaudited Financial Results for the quarter and nine months ending December 31, 2024 27-Dec, 2024 | 08:22 PM |
About Suven Pharmaceuticals
Suven Pharmaceuticals Ltd. is a Public Limited Listed company incorporated on 06/11/2018 and has its registered office in the State of Maharashtra, India. Company's Corporate Identification Number(CIN) is L24299MH2018PLC422236 and registration number is 422236. Currently Company is involved in the business activities of Manufacture of pharmaceuticals, medicinal chemical and botanical products. Company's Total Operating Revenue is Rs. 1024.99 Cr. and Equity Capital is Rs. 25.46 Cr. for the Year ended 31/03/2024.
- IndustryPharmaceuticals
- Address215 Atrium, C Wing, 8th Floor, 819-821, Andheri Kurla Road, Chakala, Mumbai Maharashtra 400093
- Contact
Management
- Mr. Annaswamy VaidheeshExecutive Chairperson
- Dr. V Prasada RajuManaging Director
- Mr. Pankaj PatwariNon Executive Director
- Ms. Shweta JalanNon Executive Director
- Ms. Matangi GowrishankarIndependent Director
- Mr. Vinod RaoIndependent Director
- Mr. K G AnanthakrishnanIndependent Director
- Mr. Pravin Rao Udhyavara BhadyaIndependent Director
FAQs on Suven Pharmaceuticals Share Price
What is the share price of Suven Pharmaceuticals?
The share price of any company is dynamic and keeps changing depending on the trade initiated. The shares have a fixed opening rate and closing rate. The share price for Suven Pharmaceuticals is ₹1,079.35 as on Jan 17, 2025.
What kind of stock is Suven Pharmaceuticals?
The Suven Pharmaceuticals is operating in the Pharmaceuticals Sector. It is classified as a Midcap stock on the BSE.
What is the Market Cap of Suven Pharmaceuticals?
The market cap of Suven Pharmaceuticals is ₹26,729.32 Cr as on Jan 17, 2025.
What are today's High and Low prices of Suven Pharmaceuticals?
Today’s highest and lowest price of Suven Pharmaceuticals are ₹1,094.00 and ₹1,066.95.
What are the 52 Week High and 52 Week Low of Suven Pharmaceuticals?
The 52-week high/low is the highest and lowest price at which Suven Pharmaceuticals stock has traded in the past 52-week or nearly a year. The 52-week high of Suven Pharmaceuticals is ₹1,359.00 and 52-week low of Suven Pharmaceuticals is ₹586.10 as on Jan 17, 2025.
How has the Suven Pharmaceuticals performed historically in terms of returns?
The Suven Pharmaceuticals has shown returns of 0.74% over the past day, -14.83% for the past month, -13.79% over 3 months, 61.52% over 1 year, 100.26% across 3 years, and 541.67% over 5 years.
What are the P/E ratio, dividend yield and PB ratio of Suven Pharmaceuticals?
P/E ratio of and PB ratio of Suven Pharmaceuticals are 109.95 and 13.51 on Jan 17, 2025. While the company gives a dividend yield of 0.0 per annum.
Trending In Market
Mutual Funds
IPO’s Open and Upcoming
Top Indices Performance
Stock Analysis
Stock Market Stats
Financial Literacy
Gold Rate Today
NSE Top Gainers
NSE Top Losers
BSE Top Gainers
BSE Top Losers
NSE 52-Week High
NSE 52-Week Low
BSE 52-Week High
BSE 52-Week Low
NSE Price Shocker
NSE Volume Shocker
BSE Price Shocker
BSE Volume Shocker
NSE Buyers
NSE Sellers
BSE Buyers
BSE Sellers
Silver Rate Today
Petrol Rate Today
Diesel Rate Today
Market Data